Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.1432
-0.0165 (-10.33%)
Sep 10, 2026, 10:47 AM EDT - Market open
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $70 million as of September 10, 2026. Its market cap has decreased by -88.89% in one year.
Market Cap
70.00M
Enterprise Value
53.04M
1-Year Change
-88.89%
Ranking
Category
Stock Price
$0.14
ChartMarket Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $70.00M, a decrease of -92.97%. That is a compound annual growth rate of -29.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 70.00M | -90.24% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 83.91M |
| Kalaris Therapeutics | 82.60M |
| Cardiff Oncology | 81.69M |
| Yarrow Bioscience | 81.51M |
| iBio, Inc. | 81.03M |
| MAIA Biotechnology | 80.90M |
| Alterity Therapeutics | 79.57M |
| OKYO Pharma | 76.10M |